Latest monoclonal antibodies News

WHO recommends two new drugs to treat Covid
TGA grants provisional determination to AstraZeneca Pty Ltd for Covid prophylaxis and treatment, tixagevimab and cilgavimab
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant 23 December
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant
Evusheld long-acting antibody combination authorised for emergency use
New analyses of two AZD7442 Covid Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
TGA grants provisional determination to AstraZeneca Pty Ltd for Covid preventative treatment, tixagevimab and cilgavimab
CSL Research and Development Day 2021
Research-industry partnership to advance biologic therapies
Australia secures additional Covid treatments
AZD7442 request for Emergency Use Authorization for Covid prophylaxis filed in US
Researchers Illuminate Working Mechanism of Important Drug Target Proteins
WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists
Melbourne-made Covid treatment could future-proof Australia